{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T09:25:50Z","timestamp":1794043550899,"version":"4.8.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000233","name":"Genome BC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000233","id-type":"DOI","asserted-by":"publisher"}]},{"name":"CDRD"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.antiviral.2019.104542","type":"journal-article","created":{"date-parts":[[2019,6,22]],"date-time":"2019-06-22T01:31:51Z","timestamp":1561167111000},"page":"104542","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Passaging of an influenza A(H1N1)pdm09 virus in a difluoro sialic acid inhibitor selects for a novel, but unfit I106M neuraminidase mutant"],"prefix":"10.1016","volume":"169","author":[{"given":"Jennifer L.","family":"McKimm-Breschkin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charley","family":"McKenzie-Kludas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"McAuley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor A.","family":"Streltsov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen G.","family":"Withers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2019.104542_bib1","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofx105","article-title":"A review of clinical influenza A and B infections with reduced susceptibility to both oseltamivir and zanamivir","volume":"4","author":"Abed","year":"2017","journal-title":"Open Forum Infect. Dis."},{"key":"10.1016\/j.antiviral.2019.104542_bib2","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.antiviral.2016.05.006","article-title":"The E119D neuraminidase mutation identified in a multidrug-resistant influenza A(H1N1)pdm09 isolate severely alters viral fitness in vitro and in animal models","volume":"132","author":"Abed","year":"2016","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2019.104542_bib3","doi-asserted-by":"crossref","first-page":"4702","DOI":"10.1021\/ja8085643","article-title":"Characterizing loop dynamics and ligand recognition in human- and avian-type influenza neuraminidases via generalized born molecular dynamics and end-point free energy calculations","volume":"131","author":"Amaro","year":"2009","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.antiviral.2019.104542_bib4","doi-asserted-by":"crossref","first-page":"7764","DOI":"10.1021\/ja0723535","article-title":"Remarkable loop flexibility in avian influenza N1 and its implications for antiviral drug design","volume":"129","author":"Amaro","year":"2007","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.antiviral.2019.104542_bib5","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/ncomms1390","article-title":"Mechanism of 150-cavity formation in influenza neuraminidase","volume":"2","author":"Amaro","year":"2011","journal-title":"Nat. Commun."},{"key":"10.1016\/j.antiviral.2019.104542_bib6","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/irv.12356","article-title":"Impact of a large deletion in the neuraminidase protein identified in a laninamivir-selected influenza A\/Brisbane\/10\/2007 (H3N2) variant on viral fitness in vitro and in ferrets","volume":"10","author":"Ann","year":"2016","journal-title":"Influenza Other Respir. Viruses"},{"key":"10.1016\/j.antiviral.2019.104542_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0023627","article-title":"Real time enzyme inhibition assays provide insights into differences in binding of neuraminidase inhibitors to wild type and mutant influenza viruses","volume":"6","author":"Barrett","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2019.104542_bib8","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1001\/jama.2009.294","article-title":"Infections with oseltamivir-resistant influenza A(H1N1) virus in the United States","volume":"301","author":"Dharan","year":"2009","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.antiviral.2019.104542_bib9","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.antiviral.2013.09.018","article-title":"Universal anti-neuraminidase antibody inhibiting all influenza A subtypes","volume":"100","author":"Doyle","year":"2013","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2019.104542_bib10","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01243-18","article-title":"Substrate binding by the second sialic acid-binding site of influenza a virus N1 neuraminidase contributes to enzymatic activity","volume":"92","author":"Du","year":"2018","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104542_bib11","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.bbrc.2012.10.095","article-title":"A single E105K mutation far from the active site of influenza B virus neuraminidase contributes to reduced susceptibility to multiple neuraminidase-inhibitor drugs","volume":"429","author":"Fujisaki","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.antiviral.2019.104542_bib12","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.antiviral.2017.08.004","article-title":"Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2015-2016","volume":"146","author":"Gubareva","year":"2017","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2019.104542_bib13","first-page":"95","article-title":"BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95\/98\/NT","volume":"41","author":"Hall","year":"1999","journal-title":"Nucleic Acids Symp. Ser."},{"key":"10.1016\/j.antiviral.2019.104542_bib14","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.antiviral.2009.03.003","article-title":"Emergence and spread of oseltamivir-resistant A(H1N1) influenza viruses in oceania, south east asia and South Africa","volume":"83","author":"Hurt","year":"2009","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2019.104542_bib15","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1128\/AAC.50.5.1872-1874.2006","article-title":"Neuraminidase inhibitor-resistant and -sensitive influenza B viruses isolated from an untreated human patient","volume":"50","author":"Hurt","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2019.104542_bib16","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1021\/ja963036t","article-title":"Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site:design, synthesis, and structural analysis of carbocyclic sialic acid analogues with potent anti-influenza activity","volume":"119","author":"Kim","year":"1997","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.antiviral.2019.104542_bib17","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1126\/science.1232552","article-title":"Mechanism-based covalent neuraminidase inhibitors with broad-spectrum influenza antiviral activity","volume":"340","author":"Kim","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2019.104542_bib18","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1099\/jgv.0.001029","article-title":"An I436N substitution confers resistance of influenza A(H1N1)pdm09 viruses to multiple neuraminidase inhibitors without affecting viral fitness","volume":"99","author":"Kwon","year":"2018","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2019.104542_bib19","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.antiviral.2018.07.001","article-title":"Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors and status of novel antivirals, 2016-2017","volume":"157","author":"Lackenby","year":"2018","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2019.104542_bib20","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0022-1759(90)90282-Z","article-title":"The use of tetramethylbenzidine for solid phase immunoassays","volume":"135","author":"McKimm-Breschkin","year":"1990","journal-title":"J. Immunol. Methods"},{"issue":"Suppl. 1","key":"10.1016\/j.antiviral.2019.104542_bib21","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/irv.12047","article-title":"Influenza neuraminidase inhibitors: antiviral action and mechanisms of resistance","volume":"7","author":"McKimm-Breschkin","year":"2013","journal-title":"Influenza Other Respir. Viruses"},{"key":"10.1016\/j.antiviral.2019.104542_bib22","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1093\/jac\/dks150","article-title":"In vitro passaging of a pandemic H1N1\/09 virus selects for viruses with neuraminidase mutations conferring high-level resistance to oseltamivir and peramivir, but not to zanamivir","volume":"67","author":"McKimm-Breschkin","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.antiviral.2019.104542_bib23","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1128\/JVI.72.3.2456-2462.1998","article-title":"Mutations in a conserved residue in the influenza virus neuraminidase active site decreases sensitivity to Neu5Ac2en-derived inhibitors","volume":"72","author":"McKimm-Breschkin","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104542_bib24","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1093\/jac\/dkt205","article-title":"Reduced susceptibility to all neuraminidase inhibitors of influenza H1N1 viruses with haemagglutinin mutations and mutations in non-conserved residues of the neuraminidase","volume":"68","author":"McKimm-Breschkin","year":"2013","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.antiviral.2019.104542_bib25","doi-asserted-by":"crossref","first-page":"552","DOI":"10.3201\/eid1504.181280","article-title":"Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007-08 season","volume":"15","author":"Meijer","year":"2009","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2019.104542_bib26","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12985-015-0295-3","article-title":"The neuraminidases of MDCK grown human influenza A(H3N2) viruses isolated since 1994 can demonstrate receptor binding","volume":"12","author":"Mohr","year":"2015","journal-title":"Virol. J."},{"key":"10.1016\/j.antiviral.2019.104542_bib27","doi-asserted-by":"crossref","first-page":"6421","DOI":"10.1021\/jm100621s","article-title":"Structural and functional basis of resistance to neuraminidase inhibitors of influenza B viruses","volume":"53","author":"Oakley","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2019.104542_bib28","series-title":"The PyMOL Molecular Graphics System","author":"Schrodinger","year":"2010"},{"key":"10.1016\/j.antiviral.2019.104542_bib29","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1093\/glycob\/10.7.649","article-title":"Influenza virus infection of desialylated cells","volume":"10","author":"Stray","year":"2000","journal-title":"Glycobiology"},{"key":"10.1016\/j.antiviral.2019.104542_bib30","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.virusres.2015.07.015","article-title":"Difluorosialic acids, potent novel influenza virus neuraminidase inhibitors, induce fewer drug resistance-associated neuraminidase mutations than does oseltamivir","volume":"210","author":"Tai","year":"2015","journal-title":"Virus Res."},{"key":"10.1016\/j.antiviral.2019.104542_bib31","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.antiviral.2016.11.007","article-title":"The I427T neuraminidase (NA) substitution, located outside the NA active site of an influenza A(H1N1)pdm09 variant with reduced susceptibility to NA inhibitors, alters NA properties and impairs viral fitness","volume":"137","author":"Tu","year":"2017","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2019.104542_bib32","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/prot.340140302","article-title":"The structure of the complex between influenza virus neuraminidase and sialic acid, the viral receptor","volume":"14","author":"Varghese","year":"1992","journal-title":"Proteins"},{"key":"10.1016\/j.antiviral.2019.104542_bib33","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0969-2126(98)00075-6","article-title":"Drug design against a shifting target: a structural basis for resistance to inhibitors in a variant of influenza virus neuraminidase","volume":"6","author":"Varghese","year":"1998","journal-title":"Structure"},{"key":"10.1016\/j.antiviral.2019.104542_bib34","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/363418a0","article-title":"Rational design of potent sialidase-based inhibitors of influenza virus replication","volume":"363","author":"von Itzstein","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2019.104542_bib35","doi-asserted-by":"crossref","first-page":"9221","DOI":"10.1128\/JVI.00697-12","article-title":"Functional balance of the hemagglutinin and neuraminidase activities accompanies the emergence of the 2009 H1N1 influenza pandemic","volume":"86","author":"Xu","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104542_bib36","doi-asserted-by":"crossref","first-page":"5935","DOI":"10.1128\/JVI.02537-14","article-title":"Pandemic swine H1N1 influenza viruses with almost undetectable neuraminidase activity are not transmitted via aerosols in ferrets and are inhibited by human mucus but not swine mucus","volume":"89","author":"Zanin","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104542_bib37","doi-asserted-by":"crossref","first-page":"18903","DOI":"10.1073\/pnas.1212579109","article-title":"Crystal structures of two subtype N10 neuraminidase-like proteins from bat influenza A viruses reveal a diverged putative active site","volume":"109","author":"Zhu","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2019.104542_bib38","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1093\/jac\/dkl321","article-title":"Mutations conferring zanamivir resistance in human influenza virus N2 neuraminidases compromise virus fitness and are not stably maintained in vitro","volume":"58","author":"Zurcher","year":"2006","journal-title":"J. Antimicrob. Chemother."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354219301913?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354219301913?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:29:22Z","timestamp":1759062562000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354219301913"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":38,"alternative-id":["S0166354219301913"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2019.104542","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Passaging of an influenza A(H1N1)pdm09 virus in a difluoro sialic acid inhibitor selects for a novel, but unfit I106M neuraminidase mutant","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2019.104542","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2019 Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104542"}}